Statera Biopharma, Inc. Annual Amortization of Intangible Assets in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Statera Biopharma, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2021.
  • Statera Biopharma, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2022 was $114K.
  • Statera Biopharma, Inc. annual Amortization of Intangible Assets for 2021 was $233K.
  • Statera Biopharma, Inc. annual Amortization of Intangible Assets for 2020 was $0.000.
  • Statera Biopharma, Inc. annual Amortization of Intangible Assets for 2011 was $13.1K, a 26.3% decline from 2010.
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $233K +$233K Jan 1, 2021 Dec 31, 2021 10-K 2022-10-06
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-10-06
2011 $13.1K -$4.7K -26.3% Jan 1, 2011 Dec 31, 2011 10-K 2012-03-13
2010 $17.9K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.